Psoriasis responds to intralesional injections of alefacept and may predict systemic response to intramuscular alefacept: Interim results of a single-arm, open-label study

By Gattu Shilpa   Busse Kristine   Bhutani Tina   Chiang Charles   Nguyen Thao   Becker Emily   Koo John Y. M.  

Journal of Dermatological Treatment, Vol. 23, Iss. 2, 2012-04 ,pp. : 103-108

Informa Healthcare

Access to resources Recommend Favorite

Alefacept in corticosteroid refractory graft versus host disease: Early results indicate promising activity

By Toor Amir   Stiff Patrick   Nickoloff Brian   Rodriguez Tulio   Klein Jared   Gordon Kenneth  

Journal of Dermatological Treatment, Vol. 18, Iss. 1, 2007-01 ,pp. : 13-18

Informa Healthcare

Access to resources Recommend Favorite

Explorative immunohistochemical study to evaluate the addition of a topical corticosteroid in the early phase of alefacept treatment for psoriasis

By Bovenschen H.   Gerritsen W.   Rens D.   Seyger M.   Jong E.   Kerkhof P.  

Archives of Dermatological Research, Vol. 298, Iss. 9, 2007-02 ,pp. : 457-463

Springer Publishing Company

Access to resources Recommend Favorite

Open label trial of alefacept in palmoplantar pustular psoriasis

By Carr David   Tusa Mark   Carroll Christie   Pearce Daniel   Camacho Fabian   Kaur Mandeep   Cook Christina   Willard Joy   McCarty Ann   Fleischer Alan   Liu Clive   Goffe Bernard   Feldman Steven  

Journal of Dermatological Treatment, Vol. 19, Iss. 2, 2008-01 ,pp. : 97-100

Informa Healthcare

Access to resources Recommend Favorite

Alefacept: A rapidly expanding role in the management of dermatologic diseases

By Kapoor Shailendra  

Journal of Dermatological Treatment, Vol. 20, Iss. 1, 2009-01 ,pp. : 3-3

Informa Healthcare

Access to resources Recommend Favorite